1. Home
  2. ANTX vs III Comparison

ANTX vs III Comparison

Compare ANTX & III Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

N/A

Current Price

$5.98

Market Cap

172.9M

Sector

Health Care

ML Signal

N/A

Logo Information Services Group Inc.

III

Information Services Group Inc.

N/A

Current Price

$5.09

Market Cap

197.1M

ML Signal

N/A

Company Overview

Basic Information
Metric
ANTX
III
Founded
2017
2006
Country
United States
United States
Employees
N/A
1500
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
172.9M
197.1M
IPO Year
2022
2006

Fundamental Metrics

Financial Performance
Metric
ANTX
III
Price
$5.98
$5.09
Analyst Decision
Buy
Buy
Analyst Count
1
1
Target Price
$2.00
$5.50
AVG Volume (30 Days)
201.3K
189.7K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
4.46%
EPS Growth
32.56
216.67
EPS
N/A
0.12
Revenue
N/A
$192,745,000.00
Revenue This Year
N/A
$3.85
Revenue Next Year
N/A
$4.34
P/E Ratio
N/A
$42.80
Revenue Growth
N/A
4.51
52 Week Low
$1.00
$3.74
52 Week High
$7.19
$6.45

Technical Indicators

Market Signals
Indicator
ANTX
III
Relative Strength Index (RSI) 59.20 59.59
Support Level $3.91 $3.86
Resistance Level $7.05 $5.36
Average True Range (ATR) 0.32 0.15
MACD -0.01 -0.02
Stochastic Oscillator 75.63 65.38

Price Performance

Historical Comparison
ANTX
III

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

About III Information Services Group Inc.

Information Services Group Inc is an AI-centered technology research and advisory firm providing digital transformation and technology advisory services that help organizations optimize performance, reduce costs, and accelerate innovation. The Company's expertise includes sourcing advisory, cloud and data analytics, managed governance and risk services, network and software advisory, technology strategy and operations design, change management, and market intelligence, serving both private- and public-sector clients globally. It operates in one segment, fact-based sourcing advisory services, and operates principally in the Americas, with generate maximum revenue in Europe and the Asia Pacific.

Share on Social Networks: